Chemo before rectal surgery, without pelvic radiation
Part of Cancer, Digestive system clinical trials.
This Phase 3 study tests whether giving chemotherapy before rectal surgery can work as well as standard treatment that usually includes pelvic radiation. It aims to reduce the need for pelvic radiation while still keeping the cancer under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rectal cancer located in the middle or lower rectum (not more than 10 cm from the anus on MRI).
- Your scan shows specific cancer depth and lymph node status (cT3N0 and/or cT1–T3N+), but not the most advanced cT4 stage.
- Your MRI must show a “safe margin” around the tumor: circumferential margin is greater than 2 mm.
- You are at least 18 years old, and your overall function is good (ECOG/WHO performance status 0 or 1).
- You cannot have cancer that has spread to other organs (no metastatic disease).
- You must be able to take the study chemo drugs (including 5-FU or related medicines) and you cannot have certain medication or health contraindications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares two treatment plans given before rectal surgery. It tests whether stronger chemotherapy alone works better than chemotherapy pills plus long-term radiation to improve outcomes for locally advanced rectal cancer.
This Phase 3 trial compares different chemotherapy and radiation combinations given before surgery for locally advanced rectal cancer, to see which one works better. It may help people get a tumor removed completely (R0 resection) and improve outcomes while comparing treatment safety and effectiveness.
This trial tests a combination of chemotherapy and radiation therapy before surgery for people with mid or low rectal cancer that hasn't spread. The goal is to see if this approach works better than current treatments.
This Phase 2 study tests a treatment plan given before surgery (neoadjuvant) along with radiation and chemotherapy (concurrent chemoradiotherapy) for locally advanced rectal cancer. It may help shrink the cancer before the next steps of care and improve control of the disease.
This Phase 3 study compares giving chemotherapy before rectal surgery versus giving it after surgery, using a tailored plan based on your risk. The goal is to see which timing helps more people with locally advanced rectal cancer stay cancer-free and live longer.
This trial looks at a specific type of rectal surgery after you’ve already finished chemo-radiation, aiming to remove the tumor while trying to preserve the anal sphincter (muscle control). It’s meant for people whose cancer can be safely operated on and who don’t have spread to distant organs.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.